Comment on: ‘Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort’
Crossref DOI link: https://doi.org/10.1038/bjc.2016.69
Published Online: 2016-04-28
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Vivaldi, Caterina
Fornaro, Lorenzo
Caparello, Chiara
Falcone, Alfredo
Vasile, Enrico
Text and Data Mining valid from 2016-04-28
Article History
First Online: 28 April 2016
Competing interests
: The authors declare no conflict of interest.